Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization

NCT03455309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcus Aureus

Interventions

BIOLOGICAL: NDV-3A
BIOLOGICAL: Placebo

Sponsor

NovaDigm Therapeutics, Inc.

Collaborators

[object Object]
[object Object]